Matthew Mossanen MD, MPH
Assistant Professor of Surgery, Harvard Medical School, Brigham and Women's Hospital, Division of Urology, Boston, MassachusettsDr. Mossanen is a graduate of the University of California, Los Angeles (UCLA) in Los Angeles, CA and he received his medical degree from the David Geffen School of Medicine at UCLA. He also holds a Master of Public Health from the Harvard T.H. Chan School of Public Health in Boston, MA. Dr. Mossanen completed a residency in Urology from the University of Washington in Seattle, WA followed by a fellowship in Urologic Oncology in the Combined Harvard Urologic Oncology Fellowship at Massachusetts General Hospital and Brigham and Women’s Hospital. Dr. Mossanen has been board certified by the American Board of Urology since 2020.
His research and clinical interests include: bladder cancer, kidney cancer, kidney masses/cysts, laparoscopic surgery, penile cancer, prostate cancer, robotic surgery, testicular cancer
Recent Contributions to PracticeUpdate:
- Pembrolizumab Monotherapy for the Treatment of High-Risk Non–Muscle Invasive Bladder Cancer Unresponsive to BCG
- 2020 Top Stories in Bladder Cancer: Nadofaragene Firadenovec Emerges as a New Treatment Option for BCG-Unresponsive Disease
- The Impact of Obesity on the Outcomes After Radical Cystectomy
- BCG Shortage and Changing Treatment Patterns for Non-Muscle-Invasive Bladder Cancer
- Renorrhaphy After Partial Nephrectomy: Considerations and Planning
- Renorrhaphy After Partial Nephrectomy: Technique
- Renal Masses in a Functionally Solitary Kidney: Surgical Considerations
- Renal Masses in a Functionally Solitary Kidney: Next Steps
- Short-Term, Intensive Chemoresection vs Standard Adjuvant Intravesical Instillations in Non–Muscle-Invasive Bladder Cancer
- Genitourinary Tumor Board: Bladder Cancer Diagnosis